Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-20

Clinical Trial Update: Needle-based Percutaneous Ablation of Liver Tumors. [NA]

View source ↗

Summary

A clinical trial evaluating needle-based percutaneous ablation for liver tumors, including hepatocellular carcinoma and metastatic liver cancer, is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: inTumo Therapeutics, Inc. | Conditions: Liver Tumors, HCC - Hepatocellular Carcinoma | NA | Status: RECRUITING